News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Esketamine, rTMS and ECT: Which is more cost-effective in treatment-resistant depression?
08 May 2026
byKanas Chan
Esketamine is more cost-effective than transcranial magnetic stimulation (rTMS) and electroconvulÂsive therapy (ECT), but not when compared with other commonly used third-line treatments for treatment-resistant depression (TRD) in Hong Kong, a multi-armed modelling study has shown.
Esketamine, rTMS and ECT: Which is more cost-effective in treatment-resistant depression?
08 May 2026
One-off prison-based HCV screening cost-effective, reduces cirrhosis, HCC, and HCV-related mortality
07 May 2026
byNatalia Reoutova
A University of Hong Kong analysis shows one-off hepatitis C virus (HCV) screening of persons in custody (PICs) to be cost-effective and reduce the rates of HCV-related compensated and decompensated cirrhosis (DC), hepatocellular carcinoma (HCC), and HCV-related mortality.







